Association of TNF, IL12, and IL23 gene polymorphisms and psoriatic arthritis: meta-analysis

References

• Verheul MK, Fearon U, Trouw LA, et al. Biomarkers for rheumatoid and psoriatic arthritis. Clin Immunol. 2015;161(1):2–10.
   PubMed Web of Science ®Google Scholar
• Coates LC, FitzGerald O, Helliwell PS, et al. Psoriasis, psoriatic arthritis, and rheumatoid arthritis: is all inflammation the same? Semin Arthritis Rheum. 2016;46(3):291–304.
   PubMed Web of Science ®Google Scholar
• Diani M, Altomare G, Reali E. T cell responses in psoriasis and psoriatic arthritis. Autoimmun Rev. 2015;14(4):286–292.
   PubMed Web of Science ®Google Scholar
• Sabat R, Philipp S, Höflich C, et al. Immunopathogenesis of psoriasis. Exp Dermatol. 2007;16:779–798.
   PubMed Web of Science ®Google Scholar
• Wolk K, Haugen HS, Xu W, et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med (Berl). 2009;87:523–536.
   PubMed Web of Science ®Google Scholar
• Belasco J, Louie JS, Gulati N, et al. Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis. Arthritis Rheumatol. 2015;67:934–944.
   PubMed Web of Science ®Google Scholar
• Fitzgerald O, Winchester R. Psoriatic arthritis: from pathogenesis to therapy. Arthritis Res Ther. 2009;11:214.
   PubMed Web of Science ®Google Scholar
• Yamamoto T. Psoriatic arthritis: from a dermatological perspective. Eur J Dermatol. 2011;21:660–666.
   PubMed Web of Science ®Google Scholar
• Gottlieb A, Korman NJ, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58:851–864.
   PubMed Web of Science ®Google Scholar
• Wittmann M, Helliwell PS. Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases. Dermatol Ther (Heidelb). 2013;3:1–15.
   PubMedGoogle Scholar
• Ritchlin C, Rahman P, Kavanaugh A, et al. Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial. Ann Rheum Dis. 2014;73:990–999.
   PubMed Web of Science ®Google Scholar
• Chandran V, Rahman P. Update on the genetics of spondyloarthritis - ankylosing spondylitis and psoriatic arthritis. Best Pract Res Clin Rheumatol. 2010;24:579–588.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Farewell VT. The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Multivariate relative risk model. Arthritis Rheum. 1995;38:845–850.
   PubMed Web of Science ®Google Scholar
• Nair RP, Duffin KC, Helms C, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways. Nat Genet. 2009;41:199.
   PubMed Web of Science ®Google Scholar
• Liu Y, Helms C, Liao W, et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 2008;4(3):e1000041.
   PubMedGoogle Scholar
• Rahman P, Snelgrove T, Peddle L, et al. A variant of the IL4 I50V single-nucleotide polymorphism is associated with erosive joint disease in psoriatic arthritis. Arthritis Rheum. 2008;58:2207–2208.
   PubMedGoogle Scholar
• Lascorz J, Hüffmeier U, Schulze-Koops H, et al. Lack of genetic association of the interleukin-4 receptor single-nucleotide polymorphisms I50V and Q551R with erosive disease in psoriatic arthritis. Arthritis Rheum. 2006;54:4023–4024.
   PubMedGoogle Scholar
• Soto-Sanchez J, Santos-Juanes J, Coto-Segura P, et al. Genetic variation at the CCR5/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis. Cytokine. 2010;50:114–116.
   PubMed Web of Science ®Google Scholar
• O’Rielly DD, Rahman P. Genetics of psoriatic arthritis. Best Pract Res Clin Rheumatol. 2014;28:673–685.
   PubMed Web of Science ®Google Scholar
• Robinson PC, Brown MA. Genetics of ankylosing spondylitis. Mol Immunol. 2014;57:2–11.
   PubMed Web of Science ®Google Scholar
• Cinar M, Dinc A, Simsek I, et al. The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study. Rheumatol Int. 2008;29:37–42.
   PubMed Web of Science ®Google Scholar
• Akar S, Soysal O, Balci A, et al. High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connection. Arthritis Res Ther. 2013;15:R21.
   PubMed Web of Science ®Google Scholar
• Brown MA. Genetics of ankylosing spondylitis. Curr Opin Rheumatol. 2010;22:126–132.
   PubMed Web of Science ®Google Scholar
• Villanova F, Di Meglio P, Nestle FO. Biomarkers in psoriasis and psoriatic arthritis. Ann Rheum Dis. 2013;72(Suppl 2):ii104–ii110.
   PubMedGoogle Scholar
• Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647.
   PubMed Web of Science ®Google Scholar
• Kitts A, Phan L, Ward M, et al. The database of short genetic variation (dbSNP). 2014 [cited 2018 Jan 8]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7786990
   Google Scholar
• Wells GA, Shea B, O’connell D, et al.The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa (ON): Ottawa Hospital Research Institute; 2009 [cited 2018 Jan 10]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
   PubMedGoogle Scholar
• ManteL N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–748.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Eirís N, González-Lara L, Santos-Juanes J, et al. Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus. J Dermatol Sci. 2014;75(3):167–172.
   PubMed Web of Science ®Google Scholar
• Cabaleiro T, Roman M, Gallo E, et al. Association between psoriasis and polymorphisms in the TNF, IL12B, and IL23R genes in Spanish patients. Eur J Dermatol. 2013;23(5):640–645.
   PubMed Web of Science ®Google Scholar
• Filer C, Ho P, Smith RL, et al. Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum. 2008;58(12):3705–3709.
   PubMedGoogle Scholar
• Chang YT, Chou CT, Yu CW, et al. Cytokine gene polymorphisms in Chinese patients with psoriasis. Br J Dermatol. 2007;156(5):899–905.
   PubMed Web of Science ®Google Scholar
• Reich K, Huffmeier U, Konig IR, et al. TNF polymorphisms in psoriasis: association of psoriatic arthritis with the promoter polymorphism TNF*-857 independent of the PSORS1 risk allele. Arthritis Rheum. 2007;56(6):2056–2064.
   PubMedGoogle Scholar
• Jadon D, Tillett W, Wallis D, et al. Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis. Rheumatology. 2013;52(2):261–266.
   PubMed Web of Science ®Google Scholar
• Popa OM, Kriegova E, Popa L, et al. Association study in Romanians confirms IL23A gene haplotype block rs2066808/rs11171806 as conferring risk to psoriatic arthritis. Cytokine. 2013;63(1):67–73.
   PubMed Web of Science ®Google Scholar
• Yang Q, Liu H, Qu L, et al. Investigation of 20 non-HLA (human leucocyte antigen) psoriasis susceptibility loci in Chinese patients with psoriatic arthritis and psoriasis vulgaris. Br J Dermatol. 2013;168(5):1060–1065.
   PubMed Web of Science ®Google Scholar
• Bowes J, Orozco G, Flynn E, et al. Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Ann Rheum Dis. 2011;70(9):1641–1644.
   PubMed Web of Science ®Google Scholar
• Giardina E, Huffmeier U, Ravindran J, et al. Tumor necrosis factor promoter polymorphism TNF*-857 is a risk allele for psoriatic arthritis independent of the PSORS1 locus. Arthritis Rheum. 2011;63(12):3801–3806.
   PubMedGoogle Scholar
• Popa OM, Bojinca M, Bojinca V, et al. A pilot study of the association of tumor necrosis factor alpha polymorphisms with psoriatic arthritis in the Romanian population. Int J Mol Sci. 2011;12(8):5052–5059.
   PubMed Web of Science ®Google Scholar
• Huffmeier U, Lascorz J, Bohm B, et al. Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. J Invest Dermatol. 2009;129(2):355–358.
   PubMed Web of Science ®Google Scholar
• Rahman P, Inman RD, Maksymowych WP, et al. Association of interleukin 23 receptor variants with psoriatic arthritis. J Rheumatol. 2009;36(1):137–140.
   PubMed Web of Science ®Google Scholar
• Van Kuijk AWR, Reinders-Blankert P, Smeets TJM, et al. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis. 2006;65(12):1551–1557.
   PubMed Web of Science ®Google Scholar
• Victor FC, Gottlieb AB, Menter A. Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis. Clin Dermatol. 2013;21(5):392–397.
   Google Scholar
• Ettehadi P, Greaves MW, Wallach D, et al. Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin Exp Immunol. 1994;96(1):146–151.
   PubMed Web of Science ®Google Scholar
• Rahman P, Siannis F, Butt C, et al. TNFalpha polymorphisms and risk of psoriatic arthritis. Ann Rheum Dis. 2006;65(7):919–923.
   PubMed Web of Science ®Google Scholar
• Zhu J, Qu H, Chen X, et al. Single nucleotide polymorphisms in the tumor necrosis factor-alpha gene promoter region alter the risk of psoriasis vulgaris and psoriatic arthritis: a meta-analysis. PLoS One. 2013;8(5):e64376.
   PubMed Web of Science ®Google Scholar
• Van Heel DA, Udalova IA, De Silva AP, et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet. 2002;11(11):1281–1289.
   PubMed Web of Science ®Google Scholar
• Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046–1055.
   PubMed Web of Science ®Google Scholar
• Nossent JC, Sagen-Johnsen S, Bakland G. Tumor necrosis factor-alpha promoter −308/238 polymorphism association with less severe disease in ankylosing spondylitis is unrelated to serum TNF-alpha and does not predict TNF inhibitor response. J Rheumatol. 2014;41(8):1675–1682.
   PubMed Web of Science ®Google Scholar
• Aita A, Basso D, Ramonda R, et al. Genetics in TNF-TNFR pathway: a complex network causing spondyloarthritis and conditioning response to anti-TNFα therapy. Chang Y-J, ed. PLoS One. 2018;13:e0194693.
   PubMed Web of Science ®Google Scholar
• Liu L, Yang X, Chen X, et al. Association between TNF-α polymorphisms and cervical cancer risk: a meta-analysis. Mol Biol Rep. 2012;39(3):2683–2688.
   PubMed Web of Science ®Google Scholar
• Jiang C, Ma X, Qi S, et al. Association between TNF-α-238G/A gene polymorphism and OCD susceptibility: a meta-analysis. Medicine (Baltimore). 2018;97:5.
   Google Scholar
• Li N, Zhou Z, Liu X, et al. Association of tumour necrosis factor alpha (TNF-α) polymorphisms with Graves’ disease: a meta-analysis. Clin Biochem. 2008;41(10–11):881–886.
   PubMed Web of Science ®Google Scholar
• Grine L, Dejager L, Libert C, et al. An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17. Cytokine Growth Factor Rev. 2015;26(1):25–33.
   PubMed Web of Science ®Google Scholar
• Lubrano E, Perrotta FM. The role of IL-17 in the treatment of psoriatic arthritis. Expert Rev Clin Immunol. 2017;13:815–821.
   PubMed Web of Science ®Google Scholar
• Karczewski J, Dobrowolska A, Rychlewska-Hańczewska A, et al. New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis. Autoimmunity. 2016;49:435–450.
   PubMed Web of Science ®Google Scholar
• Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13(5):715–725.
   PubMed Web of Science ®Google Scholar
• Parham C, Chirica M, Timans J, et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a Novel Cytokine Receptor Subunit, IL-23R. J Immunol. 2002;168(11):5699–5708.
   PubMed Web of Science ®Google Scholar
• Johnsson HJ, McInnes IB. Interleukin-12 and interleukin-23 inhibition in psoriatic arthritis. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S115–S118.
   PubMedGoogle Scholar
• Krueger GG, Langley RG, Leonardi C, et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med. 2007;356(6):580–592.
   PubMed Web of Science ®Google Scholar
• Van Den Berg WB, McInnes IB. Th17 cells and IL-17 a—focus on immunopathogenesis and immunotherapeutics. Semin Arthritis Rheum. 2013;43:158–170. Elsevier.
   PubMed Web of Science ®Google Scholar
• Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009;361(9):888–898.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Kuchroo VK. IL-12–and IL-23–induced T helper cell subsets: birds of the same feather flock together. J Exp Med. 2005;201(2):169–171.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature. 2006;441(7090):235.
   PubMed Web of Science ®Google Scholar
• Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201(2):233–240.
   PubMed Web of Science ®Google Scholar
• Patel DD, Kuchroo VK. Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions. Immunity. 2015;43(6):1040–1051.
   PubMed Web of Science ®Google Scholar
• Celis R, Planell N, Fernández-Sueiro JL, et al. Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features. Arthritis Res Ther. 2012;14(2):R93.
   PubMed Web of Science ®Google Scholar
• Cua DJ, Sherlock J, Chen YI, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003;421(6924):744.
   PubMed Web of Science ®Google Scholar
• Murphy CA, Langrish CL, Chen Y, et al. Divergent pro-and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med. 2003;198(12):1951–1957.
   PubMed Web of Science ®Google Scholar
• Zhu K-J, Zhu C-Y, Shi G, et al. Meta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis. Rheumatol Int. 2013;33(7):1785–1790.
   PubMed Web of Science ®Google Scholar
• Duffin KC, Krueger GG. Genetic variations in cytokines and cytokine receptors associated with psoriasis found by Genome-Wide Association. J Invest Dermatol. 2009;129(4):827–833.
   PubMed Web of Science ®Google Scholar
• Yin X, Low HQ, Wang L, et al. Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility. Nat Commun. 2015;6(1):6916.
   PubMedGoogle Scholar
• Zuo X, Sun L, Yin X, et al. Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis. Nat Commun. 2015;6(1):6793.
   PubMedGoogle Scholar
• Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007;80(2):273–290.
   PubMed Web of Science ®Google Scholar
• Tindall EA, Hayes VM. Comprehensive sequence analysis of the human IL23A gene defines new variation content and high rate of evolutionary conservation. DNA Res. 2010;17(2):117–122.
   PubMed Web of Science ®Google Scholar
• Lee E, Trepicchio WL, Oestreicher JL, et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med. 2004;199(1):125–130.
   PubMed Web of Science ®Google Scholar
• Costa VS, Santos AS, Fukui RT, et al. Protective effect of interleukin-23A (IL23A) haplotype variants on type 1A diabetes mellitus in a Brazilian population. Cytokine. 2013;62(2):327–333.
   PubMed Web of Science ®Google Scholar
• Chen H, Poon A, Yeung C, et al. A genetic risk score combining ten psoriasis risk loci improves disease prediction. PLoS One. 2011;6(4):e19454.
   PubMed Web of Science ®Google Scholar
• Stuart PE, Nair RP, Tsoi LC, et al. Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture. Am J Hum Genet. 2015;97(6):816–836.
   PubMed Web of Science ®Google Scholar
• Abdollahi E, Tavasolian F, Momtazi-Borojeni AA, et al. Protective role of R381Q (rs11209026) polymorphism in IL-23R gene in immune-mediated diseases: a comprehensive review. J Immunotoxicol. 2016;13(3):286–300.
   PubMed Web of Science ®Google Scholar
• Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (80). 2006;314(5804):1461–1463.
   PubMed Web of Science ®Google Scholar
• Faragó B, Magyari L, Sáfrány E, et al. Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis. Ann Rheum Dis. 2008;67(2):248–250.
   PubMed Web of Science ®Google Scholar
• Lee YH, Choi SJ, Ji JD, et al. Associations between interleukin-23R polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Inflamm Res. 2012;61(2):143–149.
   PubMed Web of Science ®Google Scholar
• Zhu K-J, Zhu C-Y, Shi G, et al. Association of IL23R polymorphisms with psoriasis and psoriatic arthritis: a meta-analysis. Inflamm Res. 2012;61(10):1149–1154.
   PubMed Web of Science ®Google Scholar
• Xu B, Ma JX, Ma XL, et al. Association between rs7517847 and rs2201841 polymorphisms in IL-23 receptor gene and risk of ankylosing spondylitis: a meta-analysis. PeerJ. 2015;3:e910.
   PubMed Web of Science ®Google Scholar
• Zhang XY, Zhang HJ, Zhang Y, et al. Identification and expression analysis of alternatively spliced isoforms of human interleukin-23 receptor gene in normal lymphoid cells and selected tumor cells. Immunogenetics. 2006;57(12):934–943.
   PubMed Web of Science ®Google Scholar
• Kim HS, Kim I, Kim JO, et al. No association between interleukin 23 receptor gene polymorphisms and systemic lupus erythematosus. Rheumatol Int. 2009;30(1):33–38.
   PubMed Web of Science ®Google Scholar
• Safrany E, Melegh B. Functional variants of the interleukin-23 receptor gene in non-gastrointestinal autoimmune diseases. Curr Med Chem. 2009;16(28):3766–3774.
   PubMed Web of Science ®Google Scholar
• Zhai Y, Xu K, Huang F, et al. Association of interleukin 23 receptor gene polymorphisms (rs10489629, rs7517847) with rheumatoid arthritis in European population: a meta-analysis. Mol Biol Rep. 2012;39(9):8987–8994.
   PubMed Web of Science ®Google Scholar
• Zhang L, Fan D, Liu L, et al. Association study of IL-12B polymorphisms susceptibility with ankylosing spondylitis in mainland Han population. PLoS One. 2015;10(6):e0130982.
   PubMed Web of Science ®Google Scholar
• Park JH, Kim YJ, Park BL, et al. Lack of association between interleukin 23 receptor gene polymorphisms and rheumatoid arthritis susceptibility. Rheumatol Int. 2009;29(7):781–786.
   PubMed Web of Science ®Google Scholar
• Louahchi S, Allam I, Berkani L, et al. Association study of single nucleotide polymorphisms of IL23R and IL17 in rheumatoid arthritis in the Algerian population. Acta Reumatol Port. 2016;41(2):151–157.
   PubMed Web of Science ®Google Scholar
• Safrany E, Szabo M, Szell M, et al. Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn’s disease and psoriasis. Inflamm Res. 2013;62(2):195–200.
   PubMed Web of Science ®Google Scholar
• Glas J, Seiderer J, Wetzke M, et al. rs1004819 is the main disease-associated IL23R variant in German Crohn’s disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PLoS One. 2007;2(9):e819.
   PubMed Web of Science ®Google Scholar
• Einarsdottir E, Koskinen LL, Dukes E, et al. IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease. BMC Med Genet. 2009;10:8.
   PubMed Web of Science ®Google Scholar